Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2025-12-29 @ 11:15 AM
Study NCT ID:
NCT04870606
Status:
COMPLETED
Last Update Posted:
2024-01-02
First Post:
2021-04-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness
Sponsor:
Suzhou Kintor Pharmaceutical Inc,
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-06
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-27
First Submit QC Date:
None
Study First Post Date:
2021-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-08-14
Results First Submit QC Date:
None
Results First Post Date:
2024-01-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-11
Last Update Post Date:
2024-01-02
Last Update Post Date Type:
ACTUAL